Accelerate Diagnostics, Inc.
Accelerate Diagnostics, Inc., commonly referred to as Accelerate, is a leading innovator in the field of diagnostic solutions, headquartered in the United States. Founded in 2012, the company has rapidly established itself within the medical diagnostics industry, focusing primarily on the development of advanced technologies for the rapid detection of infectious diseases. With a strong presence in major operational regions across North America and Europe, Accelerate's core products, including the Accelerate Pheno™ system, stand out for their ability to deliver precise results in a fraction of the time compared to traditional methods. This unique capability not only enhances patient care but also optimises antibiotic stewardship. Recognised for its commitment to improving clinical outcomes, Accelerate Diagnostics has achieved significant milestones, positioning itself as a key player in the market for rapid diagnostic solutions.
DitchCarbon Score
How does Accelerate Diagnostics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Accelerate Diagnostics, Inc.'s score of 23 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Accelerate Diagnostics, Inc.'s reported carbon emissions
In 2023, Accelerate Diagnostics, Inc. reported total carbon emissions of approximately 6,800,000,000 kg CO2e, with emissions distributed across all three scopes: 113,528,000 kg CO2e from Scope 1, 139,701,000 kg CO2e from Scope 2, and the majority, 6,800,000,000 kg CO2e, from Scope 3. This data highlights the significant impact of their upstream and downstream activities on overall emissions. Despite the substantial emissions figures, there are currently no disclosed reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of specific climate commitments or reduction strategies suggests that the company may be in the early stages of developing a comprehensive sustainability plan. As the industry increasingly prioritises climate action, it will be essential for Accelerate Diagnostics to establish clear goals and strategies to address their carbon emissions effectively.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | - | 000,000,000 |
| Scope 2 | - | 000,000,000 |
| Scope 3 | 6,800,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Accelerate Diagnostics, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
